Eva Tomiak

Canadian guideline on genetic screening for hereditary renal cell

S. Pautler, A. Pause, G. Bjarnason, 2013 .

Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.

K. Bélanger, L. Seymour, J. Jimeno, 2006, Annals of Oncology.